FIELD: medicine, in particular agent with hypolipidemic activity.
SUBSTANCE: claimed agent represents N-isopropylamide-2-(2-phenylethyl)aminoethanesulfoacid chlorohydrate which is known drug for ulcer treatment. Agent of present invention provides lowered cholesterol and triglyceride levels in serum, liver and aorta and blocks lipolysis.
EFFECT: new agent for dislipoproteinemia correction useful in treatment and prophylaxis of arteriosclerosis.
5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
| HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
| AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
| AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH HYPERLIPIDEMIA AND ATHEROSCLEROSIS | 1999 |
|
RU2164408C2 |
| ELIXIR SHOWING TOTAL TONIC AND ADAPTOGENIC ACTION | 2000 |
|
RU2171113C1 |
| AGENT FOR HYPERLIPIDEMIA CORRECTION | 1995 |
|
RU2112525C1 |
| ANTIHYPERLIPIDEMIC AGENT (VARIANTS) | 2002 |
|
RU2228746C1 |
| MEDICATION FOR PREVENTION AND TREATMENT OF ATHEROSLEROSIS | 2011 |
|
RU2468789C1 |
| AGENT BASED ON L-RHAMNOPYRANOSYL-6-O-METHYL-D-GALACTURONANE, HAVING HYPOLIPIDEMIC ACTIVITY | 2019 |
|
RU2699802C1 |
